Previous close | 3.8500 |
Open | 3.8050 |
Bid | 3.7000 x 0 |
Ask | 3.8000 x 0 |
Day's range | 3.6000 - 3.9000 |
52-week range | 3.3000 - 33.0000 |
Volume | |
Avg. volume | 1,226,731 |
Market cap | 8.11M |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings date | 24 May 2024 - 28 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.43 |
Featured Company at Respiratory Innovation Summit to Jump Start Robust PresenceDURHAM, NC and LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX), a commercial-stage medical device leader in advanced magnetic resonance imaging (MRI) of the lungs, has been selected as one of the featured companies and a poster presenter at the American Thoracic Society’s (ATS) 2024 Respiratory Innovation Summit (RIS), a testament to the value of our XENOVIEW technology seen across lung clinicians and pu
Just because a business does not make any money, does not mean that the stock will go down. For example, although...